Clinical Trial Update: Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the safety and tolerability results of PCI-24781 in patients with lymphoma, including Hodgkin lymphoma and non-Hodgkin lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• PCI-24781 (PCI-24781)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Lymphoma, Hodgkin Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-04-07